Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. (Q45985026)
Jump to navigation
Jump to search
scientific article published on 21 April 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. |
scientific article published on 21 April 2009 |
Statements
1 reference
Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. (English)
1 reference
Ellen J Scherl
1 reference
Ronald Pruitt
1 reference
Glenn L Gordon
1 reference
Mark Lamet
1 reference
Audrey Shaw
1 reference
Shirley Huang
1 reference
Shadreck Mareya
1 reference
William P Forbes
1 reference
21 April 2009
1 reference
104
1 reference
6
1 reference
1452-1459
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference